LRP6 and hepatocellular carcinoma: Inhibiting miR-610 and miR-432 enhances proliferation and tumorigenicity of HCC cells through directly suppressing multiple regulators of the Wnt/β-catenin signaling cascade, including LRP6 (Zeng et al., 2014; Jiang et al., 2015).